


Feel Good Weight Loss Clinic operates as a telehealth-focused weight management practice serving Irving, TX and surrounding communities, specializing in medically supervised obesity treatment through GLP-1 receptor agonist therapy. The clinic provides virtual consultations that eliminate travel requirements while maintaining comprehensive medical oversight for patients seeking pharmaceutical intervention for weight reduction. This model allows residents throughout the Dallas-Fort Worth metroplex to access prescription weight loss medications without the scheduling constraints of traditional in-office appointments.
The clinic's treatment protocol centers on two FDA-approved GLP-1 medications: semaglutide and liraglutide, both glucagon-like peptide-1 receptor agonists that regulate appetite and glucose metabolism. Semaglutide is administered as a once-weekly subcutaneous injection, while liraglutide follows a daily injection schedule, giving providers flexibility to match medication frequency with patient preference and lifestyle factors. These medications work by mimicking the incretin hormone GLP-1, which stimulates insulin secretion, suppresses glucagon release, and slows gastric emptying to reduce hunger signals. Patients receive their prescribed medications through 503a state-licensed compounding pharmacies, which prepare customized formulations under strict regulatory standards that differ from the mass production requirements of 503b facilities. This pharmacy partnership model ensures medication quality while potentially offering cost advantages compared to brand-name commercial products.
The telehealth consultation process at Feel Good Weight Loss Clinic includes initial medical history review, assessment of weight loss goals and previous attempts, evaluation of contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and ongoing monitoring of treatment response and side effects. Providers adjust dosing protocols based on individual tolerance and weight loss progression, typically following established titration schedules that begin with lower doses to minimize gastrointestinal side effects like nausea and diarrhea. The virtual care model includes regular check-ins to track body weight changes, review any adverse reactions, and provide guidance on nutrition and physical activity modifications that complement pharmacological intervention. This approach recognizes that GLP-1 medications function most effectively when combined with behavioral modifications rather than serving as standalone solutions.
Patients beginning treatment at Feel Good Weight Loss Clinic should anticipate an initial consultation conducted via secure video platform, during which medical history, current medications, and weight loss objectives are documented. Following prescription approval, medications are shipped directly from the compounding pharmacy partner with detailed administration instructions and injection supplies. The clinic's providers educate patients on proper subcutaneous injection technique, typically into the abdomen or thigh, and establish expectations for gradual weight reduction rather than rapid loss. Common side effects during the initial weeks include nausea, constipation, and reduced appetite, which generally diminish as the body adjusts to the medication. Patients maintain communication with the clinic through messaging platforms and scheduled follow-up video appointments to ensure safe continuation of therapy and appropriate dose escalation.
The clinic's 5.0-star rating across five Google reviews reflects patient experiences with the telehealth service model and treatment outcomes, though the limited review volume represents a developing practice presence in the Irving market. The virtual-only structure eliminates geographic barriers for patients across Texas who meet eligibility criteria for remote prescribing of weight loss medications, while the compounding pharmacy partnership provides an alternative to retail pharmacy channels where GLP-1 medications have faced supply constraints and high out-of-pocket costs. Feel Good Weight Loss Clinic positions itself within the expanding telehealth weight management sector, offering access to evidence-based pharmacotherapy for patients with BMI above 30 kg/m² or above 27 kg/m² with weight-related comorbidities such as hypertension or type 2 diabetes.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


